Orphan drugs to treat rare disease

Orphan drugs are often exceedingly expensive which beg the question of how much should we pay for a drug and how do we measure effectiveness?

An examination of medical ethics and the practitioners who define them. Sign up to receive the Second Opinion topics in newsletter form at kcrw.com/newsletters .